These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34070409)

  • 21. Choline kinase: An underappreciated rheumatoid arthritis therapeutic target.
    Miriam Jose A; Rasool M
    Life Sci; 2022 Nov; 309():121031. PubMed ID: 36206833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
    Arlauckas SP; Popov AV; Delikatny EJ
    Mol Cancer Ther; 2014 Sep; 13(9):2149-58. PubMed ID: 25028471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
    Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
    Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.
    Su JS; Woods SM; Ronen SM
    NMR Biomed; 2012 Feb; 25(2):379-88. PubMed ID: 22253088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer bisquaternary heterocyclic compounds: a ras-ional design.
    Campos J; Núñez C; Díaz JJ; Sánchez RM; Gallo MA; Espinosa A
    Farmaco; 2003 Mar; 58(3):221-9. PubMed ID: 12620418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase.
    Campos J; del Carmen Núñez M; Rodríguez V; Entrena A; Hernández-Alcoceba R; Fernández F; Lacal JC; Gallo MA; Espinosa A
    Eur J Med Chem; 2001 Mar; 36(3):215-25. PubMed ID: 11337100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.
    Conejo-García A; Báñez-Coronel M; Sánchez-Martín RM; Rodríguez-González A; Ramos A; Ramírez de Molina A; Espinosa A; Gallo MA; Campos JM; Lacal JC
    J Med Chem; 2004 Oct; 47(22):5433-40. PubMed ID: 15481981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S; López-Cara LC; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Espinosa A; Marco C; Entrena A
    Bioorg Med Chem; 2013 Nov; 21(22):7146-54. PubMed ID: 24080101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
    Schiaffino-Ortega S; Baglioni E; Mariotto E; Bortolozzi R; Serrán-Aguilera L; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Hurtado-Guerrero R; Marco C; Basso G; Viola G; Entrena A; López-Cara LC
    Sci Rep; 2016 Mar; 6():23793. PubMed ID: 27029499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
    Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
    Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
    Lacal JC; Campos JM
    Mol Cancer Ther; 2015 Jan; 14(1):31-9. PubMed ID: 25487918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choline kinase inhibition in rheumatoid arthritis.
    Guma M; Sanchez-Lopez E; Lodi A; Garcia-Carbonell R; Tiziani S; Karin M; Lacal JC; Firestein GS
    Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B; Conejo-García A; Ríos-Marco P; Carrasco-Jiménez MP; Segovia J; Marco C; Gallo MA; Espinosa A; Entrena A
    Eur J Med Chem; 2012 Apr; 50():154-62. PubMed ID: 22348828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells.
    Sanchez-Lopez E; Zimmerman T; Gomez del Pulgar T; Moyer MP; Lacal Sanjuan JC; Cebrian A
    Cell Death Dis; 2013 Nov; 4(11):e933. PubMed ID: 24287694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.
    Falcon SC; Hudson CS; Huang Y; Mortimore M; Golec JM; Charlton PA; Weber P; Sundaram H
    Oncogenesis; 2013; 2(3):e38. PubMed ID: 25522435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.
    Srivani P; Sastry GN
    J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V; McSorley T; See Too WC; Konrad M; Campos JM
    ChemMedChem; 2012 Apr; 7(4):663-9. PubMed ID: 22278967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choline kinase inhibitory effect and antiproliferative activity of new 1,1',1"-(benzene-1,3,5-triylmethylene)tris[4-[(disubstituted)amino]pyridinium] tribromides.
    Conejo-García A; Campos J; Sánchez RM; Rodríguez-González A; Lacal JC; Gallo MA; Espinosa A
    Eur J Med Chem; 2003 Jan; 38(1):109-16. PubMed ID: 12593921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.
    Gallego-Ortega D; Gómez del Pulgar T; Valdés-Mora F; Cebrián A; Lacal JC
    Adv Enzyme Regul; 2011; 51(1):183-94. PubMed ID: 21035492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symmetrical bis-quinolinium compounds: new human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line.
    Sánchez-Martín R; Campos JM; Conejo-García A; Cruz-López O; Báñez-Coronel M; Rodríguez-González A; Gallo MA; Lacal JC; Espinosa A
    J Med Chem; 2005 May; 48(9):3354-63. PubMed ID: 15857141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.